Conventional wisdom says that investors are fleeing biotech and cleantech. So it's surprising to hear that Cambridge-based Flagship Ventures has raised its biggest fund so far — $270 million — explicitly to invest in those two sectors, where companies can require large amounts of capital and long gestation periods.
Flagship managing partner Noubar Afeyan told me last night, "I think the remaining limited partners who want to be in venture capital" — the pension funds, wealthy individuals, and university endowments that give VCs money to manage — "are looking for differentiated strategies, and they're looking for track records."
To read the full, original article click on this link: Cambridge's Flagship Ventures announces new $270 million fund focused on healthcare and sustainability - Innovation Economy - Boston.com
